新兴的治疗方法和当前的标准在肺癌类瘤管理
Danielle I Aronowitz1, Kevin Hyman
1Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Northwell Health, New Hyde Park, New York, NY, USA.
Current opinion in pulmonary medicine
|April 23, 2025
概括
肺癌类瘤虽然很少见,但越来越多地通过除手术之外的疗法来治疗. 先进的治疗包括由多学科团队量身定制的激素,细胞毒性,辐射和支骨内膜策略.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 肺癌类瘤是一种罕见的肺瘤,具有独特的特征.
- 了解它们独特的组织病理学和临床表现对于有效的管理至关重要.
研究的目的:
- 审查肺癌瘤的表现和管理.
- 为突出针对晚期和转移性疾病的最近临床试验.
主要方法:
- 文献综述侧重于呈现,组织病理学和治疗策略.
- 对近期临床试验的分析,针对晚期和转移性肺癌性瘤的治疗.
主要成果:
- 手术切除主要用于局部和局部区域传播的瘤.
- 系统性荷尔蒙/细胞毒性疗法,辐射和脑内支气管治疗方法正在扩大治疗选择.
- 治疗决策取决于瘤的阶段,负担,患者的状态和外科的耐受性.
结论:
- 肺癌类瘤的治疗已经超出了手术切除的范围.
- 新的全身疗法,辐射和内支气管干预提供了新的途径.
- 个性化治疗计划需要多学科的团队方法.
相关概念视频
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Cystic Fibrosis: Management
95
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
95
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.4K
COPD: Management Using Bronchodilators and Corticosteroids
122
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
122


